Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Common Stock | 0 | $0 | $1.34 | Apr 5, 2024 | Direct |
NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Restricted Stock Unit | 0 | $0 | $1.34 | Apr 5, 2024 | Direct |
NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Stock Option (Right to Buy) | 0 | Apr 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NGM | NGM BIOPHARMACEUTICALS INC | Mar 26, 2024 | 7 | $0 | 4 | Apr 8, 2024 | General Counsel, Chief Compliance Officer and Secretary |
NGM | NGM BIOPHARMACEUTICALS INC | Jan 16, 2024 | 1 | -$6.73K | 4 | Jan 18, 2024 | SVP, GC & CCO |
NGM | NGM BIOPHARMACEUTICALS INC | Nov 6, 2023 | 6 | $0 | 4 | Nov 8, 2023 | SVP, GC & CCO |
NGM | NGM BIOPHARMACEUTICALS INC | Mar 2, 2023 | 3 | $0 | 4 | Mar 6, 2023 | SVP, GC & CCO |
NGM | NGM BIOPHARMACEUTICALS INC | Mar 3, 2022 | 1 | $0 | 4 | Mar 4, 2022 | SVP, GC & CCO |